메뉴 건너뛰기




Volumn 40, Issue 8, 2012, Pages 1473-1477

Boosting of HIV protease inhibitors by ritonavir in the intestine: The relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice

Author keywords

[No Author keywords available]

Indexed keywords

AMINOBENZOTRIAZOLE; AMPRENAVIR; ATAZANAVIR; BENZOTRIAZOLE DERIVATIVE; CYTOCHROME P450; DARUNAVIR; GLYCOPROTEIN P; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INDINAVIR; LOPINAVIR; NELFINAVIR; RITONAVIR; SAQUINAVIR; TIPRANAVIR; UNCLASSIFIED DRUG;

EID: 84863902252     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.044677     Document Type: Article
Times cited : (51)

References (20)
  • 1
    • 34247612824 scopus 로고    scopus 로고
    • In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: Illustration of intraluminal supersaturation
    • Brouwers J, Tack J, and Augustijns P (2007) In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation. Int J Pharm 336:302-309.
    • (2007) Int J Pharm , vol.336 , pp. 302-309
    • Brouwers, J.1    Tack, J.2    Augustijns, P.3
  • 2
    • 0034807802 scopus 로고    scopus 로고
    • Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate
    • Cummins CL, Mangravite LM, and Benet LZ (2001) Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharm Res 18:1102-1109.
    • (2001) Pharm Res , vol.18 , pp. 1102-1109
    • Cummins, C.L.1    Mangravite, L.M.2    Benet, L.Z.3
  • 3
    • 0037677559 scopus 로고    scopus 로고
    • P-glycoprotein attenuating effect of human intestinal fluid
    • Deferme S, Tack J, Lammert F, and Augustijns P (2003) P-glycoprotein attenuating effect of human intestinal fluid. Pharm Res 20:900-903.
    • (2003) Pharm Res , vol.20 , pp. 900-903
    • Deferme, S.1    Tack, J.2    Lammert, F.3    Augustijns, P.4
  • 5
    • 70449440262 scopus 로고    scopus 로고
    • How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials
    • Hill A, van der Lugt J, Sawyer W, and Boffito M (2009) How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials. AIDS 23:2237-2245.
    • (2009) AIDS , vol.23 , pp. 2237-2245
    • Hill, A.1    Van Der Lugt, J.2    Sawyer, W.3    Boffito, M.4
  • 6
    • 77956008536 scopus 로고    scopus 로고
    • In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal P-glycoprotein by ritonavir causing increased darunavir absorption
    • Holmstock N, Mols R, Annaert P, and Augustijns P (2010) In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal P-glycoprotein by ritonavir causing increased darunavir absorption. Drug Metab Dispos 38:1407-1410.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1407-1410
    • Holmstock, N.1    Mols, R.2    Annaert, P.3    Augustijns, P.4
  • 7
    • 79959359682 scopus 로고    scopus 로고
    • Ritonavir-boosted protease inhibitors in HIV therapy
    • Hull MW and Montaner JS (2011) Ritonavir-boosted protease inhibitors in HIV therapy. Ann Med 43:375-388.
    • (2011) Ann Med , vol.43 , pp. 375-388
    • Hull, M.W.1    Montaner, J.S.2
  • 8
    • 1842557505 scopus 로고    scopus 로고
    • Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
    • Ingels F, Beck B, Oth M, and Augustijns P (2004) Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int J Pharm 274:221-232.
    • (2004) Int J Pharm , vol.274 , pp. 221-232
    • Ingels, F.1    Beck, B.2    Oth, M.3    Augustijns, P.4
  • 9
    • 72749106653 scopus 로고    scopus 로고
    • The complexities of antiretroviral drug-drug interactions: Role of ABC and SLC transporters
    • Kis O, Robillard K, Chan GN, and Bendayan R (2010) The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol Sci 31:22-35.
    • (2010) Trends Pharmacol Sci , vol.31 , pp. 22-35
    • Kis, O.1    Robillard, K.2    Chan, G.N.3    Bendayan, R.4
  • 11
    • 67650084777 scopus 로고    scopus 로고
    • Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs
    • Matsson P, Pedersen JM, Norinder U, Bergström CA, and Artursson P (2009) Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res 26:1816-1831.
    • (2009) Pharm Res , vol.26 , pp. 1816-1831
    • Matsson, P.1    Pedersen, J.M.2    Norinder, U.3    Bergström, C.A.4    Artursson, P.5
  • 12
    • 0034812580 scopus 로고    scopus 로고
    • Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures
    • Mohri K and Uesawa Y (2001) Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures. Pharm Res 18:1232-1236.
    • (2001) Pharm Res , vol.18 , pp. 1232-1236
    • Mohri, K.1    Uesawa, Y.2
  • 13
    • 66649103351 scopus 로고    scopus 로고
    • Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: Evaluation of a novel tool in biopharmaceutical drug profiling
    • Mols R, Brouwers J, Schinkel AH, Annaert P, and Augustijns P (2009) Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: evaluation of a novel tool in biopharmaceutical drug profiling. Drug Metab Dispos 37:1334-1337.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1334-1337
    • Mols, R.1    Brouwers, J.2    Schinkel, A.H.3    Annaert, P.4    Augustijns, P.5
  • 14
    • 0034932521 scopus 로고    scopus 로고
    • Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man
    • Salphati L, Childers K, Pan L, Tsutsui K, and Takahashi L (2001) Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J Pharm Pharmacol 53:1007-1013.
    • (2001) J Pharm Pharmacol , vol.53 , pp. 1007-1013
    • Salphati, L.1    Childers, K.2    Pan, L.3    Tsutsui, K.4    Takahashi, L.5
  • 15
    • 78649885201 scopus 로고    scopus 로고
    • Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir
    • Sevrioukova IF and Poulos TL (2010) Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir. Proc Natl Acad Sci USA 107:18422-18427.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 18422-18427
    • Sevrioukova, I.F.1    Poulos, T.L.2
  • 17
    • 79953686193 scopus 로고    scopus 로고
    • Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
    • Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, and Terasaki T (2011) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333-345.
    • (2011) J Neurochem , vol.117 , pp. 333-345
    • Uchida, Y.1    Ohtsuki, S.2    Katsukura, Y.3    Ikeda, C.4    Suzuki, T.5    Kamiie, J.6    Terasaki, T.7
  • 18
    • 63849123835 scopus 로고    scopus 로고
    • Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects
    • Vermeir M, Lachau-Durand S, Mannens G, Cuyckens F, van Hoof B, and Raoof A (2009) Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects. Drug Metab Dispos 37:809-820.
    • (2009) Drug Metab Dispos , vol.37 , pp. 809-820
    • Vermeir, M.1    Lachau-Durand, S.2    Mannens, G.3    Cuyckens, F.4    Van Hoof, B.5    Raoof, A.6
  • 20
    • 0346025675 scopus 로고    scopus 로고
    • Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
    • Zeldin RK and Petruschke RA (2004) Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J Antimicrob Chemother 53:4-9.
    • (2004) J Antimicrob Chemother , vol.53 , pp. 4-9
    • Zeldin, R.K.1    Petruschke, R.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.